Profil
Stefan Proniuk worked as a Scientist at CIMA Labs, Inc. from 2000 to 2002.
He then worked as a Senior Manager-Pharmaceutical Technologies at Neurocrine Biosciences, Inc. from 2002 to 2008.
From 2008 to 2017, he served as the Chief Development Officer at Arno Therapeutics, Inc. Dr. Proniuk holds an MBA from San Diego State University and a doctorate from the University of Arizona.
Anciens postes connus de Stefan Proniuk
| Sociétés | Poste | Fin |
|---|---|---|
| ARNO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2017 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2008 |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2002 |
Formation de Stefan Proniuk
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arno Therapeutics, Inc.
Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
















